JNJ
Johnson & Johnson
—
228.39 $
-5.8100 (%-2.48)
Previous Close: 234.2
Day Low₺227.61
Day High₺232.75
JNJ: Johnson & Johnson Financials
JNJ Income Statement
Total revenue
Net income
Gross margin TTM
72.78%
Operating margin TTM
27.17%
Net profit margin TTM
28.46%
Return on investment TTM
—
| Period end | 28/12/2025 | 29/12/2024 | 31/12/2023 | 01/01/2023 |
|---|---|---|---|---|
| Total revenue | 94,193,000,000 | 88,821,000,000 | 85,159,000,000 | 79,990,000,000 |
| Operating income | 25,596,000,000 | 22,149,000,000 | 23,409,000,000 | 21,013,000,000 |
| Net income | 26,804,000,000 | 14,066,000,000 | 35,153,000,000 | 17,941,000,000 |
All line items
| Line item | 28/12/2025 | 29/12/2024 | 31/12/2023 | 01/01/2023 |
|---|---|---|---|---|
| Total revenue | 94,193,000,000 | 88,821,000,000 | 85,159,000,000 | 79,990,000,000 |
| Cost of revenue | 25,635,000,000 | 27,471,000,000 | 26,553,000,000 | 24,596,000,000 |
| Gross profit | 68,558,000,000 | 61,350,000,000 | 58,606,000,000 | 55,394,000,000 |
| Research and development expenses | 14,665,000,000 | 17,232,000,000 | 15,085,000,000 | 14,135,000,000 |
| General and administrative expenses | 23,676,000,000 | 21,969,000,000 | 20,112,000,000 | 20,246,000,000 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 23,676,000,000 | 21,969,000,000 | 20,112,000,000 | 20,246,000,000 |
| Other expenses | 4,621,000,000 | 0 | 0 | 0 |
| Operating expenses | 42,962,000,000 | 39,201,000,000 | 35,197,000,000 | 34,381,000,000 |
| Cost and expenses | 68,597,000,000 | 66,672,000,000 | 61,750,000,000 | 58,977,000,000 |
| Net interest income | 85,000,000 | 577,000,000 | 489,000,000 | 214,000,000 |
| Interest income | 1,056,000,000 | 1,332,000,000 | 1,261,000,000 | 490,000,000 |
| Interest expense | 971,000,000 | 755,000,000 | 772,000,000 | 276,000,000 |
| Depreciation and amortization | 7,503,000,000 | 7,339,000,000 | 7,486,000,000 | 6,970,000,000 |
| EBITDA | 41,055,000,000 | 24,781,000,000 | 23,320,000,000 | 26,605,000,000 |
| EBIT | 33,552,000,000 | 17,442,000,000 | 15,834,000,000 | 19,635,000,000 |
| Non-operating income (excl. interest) | -7,956,000,000 | 4,707,000,000 | 7,575,000,000 | 1,378,000,000 |
| Operating income | 25,596,000,000 | 22,149,000,000 | 23,409,000,000 | 21,013,000,000 |
| Total other income/expenses (net) | 6,985,000,000 | -5,462,000,000 | -8,347,000,000 | -1,654,000,000 |
| Income before tax | 32,581,000,000 | 16,687,000,000 | 15,062,000,000 | 19,359,000,000 |
| Income tax expense | 5,777,000,000 | 2,621,000,000 | 1,736,000,000 | 2,989,000,000 |
| Net income from continuing operations | 26,804,000,000 | 14,066,000,000 | 13,326,000,000 | 16,370,000,000 |
| Net income from discontinued operations | 0 | 0 | 21,827,000,000 | 1,571,000,000 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 26,804,000,000 | 14,066,000,000 | 35,153,000,000 | 17,941,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | 26,804,000,000 | 14,066,000,000 | 35,153,000,000 | 17,941,000,000 |
| EPS | 11 | 6 | 14 | 7 |
| Diluted EPS | 11 | 6 | 14 | 7 |
| Weighted average shares outstanding | 2,428,600,000 | 2,407,300,000 | 2,533,500,000 | 2,613,597,000 |
| Weighted average diluted shares outstanding | 2,429,400,000 | 2,429,400,000 | 2,560,400,000 | 2,663,900,000 |